<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266699/" ref="ordinalpos=781&amp;ncbi_uid=6969046&amp;link_uid=PMC4266699" image-link="/pmc/articles/PMC4266699/figure/fig02/" class="imagepopup">Figure 2.  From: Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors. </a></div><br /><div class="p4l_captionBody">Redundant kinase signaling pathway. The activation of redundant kinase leads to downstream pathway such as PI3K/AKT, RAS/RAF/MEK and JAK/STAT signaling actived, which offsets the blockade of EGFR pathway by TKIs.</div></div>